PPARγ activation enhances the function of anti-tumor immune cells, such as CD8 + T cells and natural killer (NK) cells, by promoting the secretion of anti-inflammatory cytokines like IL-10 and TGF-β in tumor-associated macrophages [112]. The gene discussed is CD8A; the disease is neoplasm.